buthionine sulfoximine has been researched along with Cancer of Kidney in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakehi, Y; Ogawa, O; Wu, XX | 1 |
| Hirai, Y; Iwakawa, S; Kawabe, N; Miyamoto, S; Tsuda, Y | 1 |
| al-Nabulsi, I; Belldegrun, A; Friedman, N; Kasid, U; Leung, SW; Mitchell, JB; Newsome, J | 1 |
| Mizutani, Y; Yoshida, O | 1 |
| Alken, PM; Forster, S; Koessig, J; Mickisch, GH; Roehrich, K; Tschada, RK | 1 |
| Larsson, R; Nygren, P | 1 |
6 other study(ies) available for buthionine sulfoximine and Cancer of Kidney
| Article | Year |
|---|---|
Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Renal Cell; Caspases; Cell Division; Doxorubicin; Drug Synergism; Fluorouracil; Glutathione; Glutathione Transferase; Humans; Kidney Neoplasms; Oxidation-Reduction; Oxides; Tumor Cells, Cultured; Vinblastine | 2004 |
Effect of 2-methoxyestradiol, buthionine sulfoximine and hydrogen peroxide on the viability of renal carcinoma cell lines (ACHN and ACVB).
Topics: 2-Methoxyestradiol; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Estradiol; Glutathione; Humans; Hydrogen Peroxide; Kidney Neoplasms; Reactive Oxygen Species | 2006 |
Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines.
Topics: Animals; Buthionine Sulfoximine; Carcinoma, Renal Cell; Cell Adhesion; Cell Division; Cell Survival; Glutamate-Cysteine Ligase; Glutathione; Humans; Kidney Neoplasms; Male; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Nude; Phenotype; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1993 |
Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensi
Topics: Acetylcysteine; Antimetabolites, Antineoplastic; Blotting, Northern; Buthionine Sulfoximine; Carcinoma, Renal Cell; Down-Regulation; Drug Resistance; Drug Synergism; Female; Glutathione; Humans; Kidney Neoplasms; Methionine Sulfoximine; Ovarian Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
Topics: Antimetabolites; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Carboplatin; Carcinoma, Renal Cell; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Humans; In Vitro Techniques; Kidney Neoplasms; Membrane Glycoproteins; Methionine Sulfoximine; Neoplasm Proteins; Organoplatinum Compounds; Oxidation-Reduction; Verapamil; Vinblastine | 1990 |
Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Topics: Adenocarcinoma; Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cell Line; Cell Survival; Cisplatin; Cyclosporins; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lymphocytes; Methionine Sulfoximine; Neurilemmoma; Tumor Cells, Cultured; Verapamil; Vincristine | 1991 |